Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 40962 | 24.3 |
09:34 ET | 622 | 24.29 |
09:36 ET | 1200 | 24.35 |
09:38 ET | 3050 | 24.21 |
09:39 ET | 500 | 24.3 |
09:41 ET | 1380 | 24.29 |
09:43 ET | 1504 | 24.36 |
09:45 ET | 1900 | 24.28 |
09:48 ET | 300 | 24.31 |
09:50 ET | 1400 | 24.32 |
09:52 ET | 300 | 24.325 |
09:54 ET | 700 | 24.3 |
09:56 ET | 1340 | 24.38 |
09:57 ET | 3000 | 24.3799 |
09:59 ET | 1000 | 24.35 |
10:01 ET | 1367 | 24.365 |
10:03 ET | 2881 | 24.37 |
10:06 ET | 2071 | 24.38 |
10:08 ET | 6286 | 24.35 |
10:10 ET | 2348 | 24.33 |
10:12 ET | 500 | 24.335 |
10:14 ET | 905 | 24.35 |
10:15 ET | 1957 | 24.36 |
10:17 ET | 1200 | 24.39 |
10:19 ET | 1105 | 24.4 |
10:21 ET | 300 | 24.42 |
10:24 ET | 999 | 24.43 |
10:26 ET | 1841 | 24.41 |
10:28 ET | 1100 | 24.38 |
10:30 ET | 400 | 24.37 |
10:33 ET | 500 | 24.38 |
10:35 ET | 4007 | 24.36 |
10:37 ET | 827 | 24.35 |
10:39 ET | 3561 | 24.36 |
10:42 ET | 6890 | 24.34 |
10:44 ET | 3363 | 24.35 |
10:46 ET | 2793 | 24.355 |
10:48 ET | 500 | 24.355 |
10:50 ET | 2195 | 24.37 |
10:51 ET | 3911 | 24.3893 |
10:53 ET | 2300 | 24.37 |
10:55 ET | 1900 | 24.39 |
10:57 ET | 100 | 24.39 |
11:00 ET | 2766 | 24.37 |
11:02 ET | 1304 | 24.38 |
11:04 ET | 1000 | 24.38 |
11:06 ET | 1057 | 24.39 |
11:08 ET | 27407 | 24.43 |
11:09 ET | 117352 | 24.4 |
11:11 ET | 1239 | 24.37 |
11:13 ET | 32333 | 24.37 |
11:15 ET | 1100 | 24.385 |
11:18 ET | 1700 | 24.36 |
11:20 ET | 1200 | 24.37 |
11:22 ET | 1268 | 24.36 |
11:24 ET | 3123 | 24.37 |
11:26 ET | 3698 | 24.35 |
11:27 ET | 1200 | 24.39 |
11:29 ET | 1600 | 24.39 |
11:31 ET | 200 | 24.39 |
11:33 ET | 2476 | 24.37 |
11:36 ET | 225 | 24.375 |
11:38 ET | 8408 | 24.4 |
11:40 ET | 600 | 24.4 |
11:42 ET | 2393 | 24.4 |
11:44 ET | 2761 | 24.395 |
11:45 ET | 700 | 24.4 |
11:47 ET | 700 | 24.41 |
11:49 ET | 2200 | 24.4 |
11:51 ET | 300 | 24.42 |
11:54 ET | 1747 | 24.425 |
11:56 ET | 700 | 24.42 |
11:58 ET | 2409 | 24.44 |
12:00 ET | 1910 | 24.44 |
12:02 ET | 1453 | 24.41 |
12:03 ET | 750 | 24.42 |
12:05 ET | 652 | 24.43 |
12:07 ET | 1700 | 24.455 |
12:09 ET | 3357 | 24.435 |
12:12 ET | 24751 | 24.35 |
12:14 ET | 1555 | 24.38 |
12:16 ET | 3700 | 24.395 |
12:18 ET | 4678 | 24.37 |
12:21 ET | 6524 | 24.35 |
12:23 ET | 3555 | 24.31 |
12:25 ET | 600 | 24.3 |
12:27 ET | 3500 | 24.27 |
12:30 ET | 1200 | 24.26 |
12:32 ET | 400 | 24.22 |
12:34 ET | 1705 | 24.26 |
12:36 ET | 14015 | 24.29 |
12:38 ET | 3704 | 24.26 |
12:39 ET | 200 | 24.26 |
12:41 ET | 4449 | 24.28 |
12:43 ET | 100 | 24.28 |
12:45 ET | 3305 | 24.2906 |
12:48 ET | 400 | 24.28 |
12:50 ET | 2826 | 24.29 |
12:52 ET | 1500 | 24.3 |
12:54 ET | 3979 | 24.32 |
12:56 ET | 100 | 24.32 |
12:57 ET | 1569 | 24.3 |
12:59 ET | 600 | 24.29 |
01:01 ET | 1759 | 24.29 |
01:03 ET | 699 | 24.29 |
01:06 ET | 1000 | 24.29 |
01:08 ET | 3227 | 24.295 |
01:10 ET | 500 | 24.3 |
01:12 ET | 3468 | 24.29 |
01:14 ET | 3915 | 24.29 |
01:15 ET | 392 | 24.29 |
01:17 ET | 700 | 24.32 |
01:19 ET | 1348 | 24.325 |
01:21 ET | 1033 | 24.32 |
01:24 ET | 2486 | 24.32 |
01:26 ET | 632 | 24.315 |
01:28 ET | 600 | 24.31 |
01:30 ET | 500 | 24.315 |
01:32 ET | 1502 | 24.315 |
01:33 ET | 100 | 24.315 |
01:35 ET | 1114 | 24.295 |
01:37 ET | 1600 | 24.285 |
01:39 ET | 500 | 24.285 |
01:42 ET | 1141 | 24.285 |
01:44 ET | 7202 | 24.275 |
01:46 ET | 1225 | 24.27 |
01:48 ET | 2400 | 24.255 |
01:50 ET | 400 | 24.25 |
01:51 ET | 500 | 24.25 |
01:53 ET | 5111 | 24.23 |
01:55 ET | 750 | 24.22 |
01:57 ET | 2406 | 24.225 |
02:00 ET | 1100 | 24.24 |
02:02 ET | 1636 | 24.27 |
02:04 ET | 3039 | 24.23 |
02:06 ET | 900 | 24.24 |
02:08 ET | 1351 | 24.25 |
02:09 ET | 1701 | 24.265 |
02:11 ET | 2956 | 24.26 |
02:13 ET | 3015 | 24.27 |
02:15 ET | 1016 | 24.24 |
02:18 ET | 1647 | 24.255 |
02:20 ET | 2039 | 24.25 |
02:22 ET | 300 | 24.255 |
02:24 ET | 3400 | 24.265 |
02:26 ET | 4127 | 24.31 |
02:27 ET | 1500 | 24.29 |
02:29 ET | 100 | 24.29 |
02:31 ET | 400 | 24.295 |
02:33 ET | 200 | 24.295 |
02:36 ET | 300 | 24.295 |
02:38 ET | 15091 | 24.22 |
02:40 ET | 754 | 24.22 |
02:42 ET | 5531 | 24.21 |
02:44 ET | 1803 | 24.185 |
02:45 ET | 1900 | 24.2 |
02:47 ET | 2789 | 24.2 |
02:49 ET | 600 | 24.205 |
02:51 ET | 2441 | 24.18 |
02:54 ET | 2000 | 24.2 |
02:56 ET | 1509 | 24.21 |
02:58 ET | 1503 | 24.2 |
03:00 ET | 1740 | 24.2 |
03:02 ET | 200 | 24.205 |
03:03 ET | 2909 | 24.175 |
03:05 ET | 2650 | 24.205 |
03:07 ET | 2077 | 24.225 |
03:09 ET | 3386 | 24.215 |
03:12 ET | 1454 | 24.22 |
03:14 ET | 3443 | 24.23 |
03:16 ET | 200 | 24.23 |
03:18 ET | 2077 | 24.24 |
03:20 ET | 53176 | 24.23 |
03:21 ET | 30900 | 24.21 |
03:23 ET | 400 | 24.21 |
03:25 ET | 6902 | 24.225 |
03:27 ET | 4738 | 24.18 |
03:30 ET | 2393 | 24.18 |
03:32 ET | 5449 | 24.205 |
03:34 ET | 5165 | 24.215 |
03:36 ET | 5299 | 24.19 |
03:38 ET | 4480 | 24.16 |
03:39 ET | 2483 | 24.155 |
03:41 ET | 511 | 24.15 |
03:43 ET | 12567 | 24.14 |
03:45 ET | 6605 | 24.16 |
03:48 ET | 3497 | 24.155 |
03:50 ET | 3829 | 24.135 |
03:52 ET | 10988 | 24.17 |
03:54 ET | 13188 | 24.125 |
03:56 ET | 22197 | 24.125 |
03:57 ET | 39348 | 24.15 |
03:59 ET | 333596 | 24.15 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.1B | 32.3x | -21.77% |
PTC Therapeutics Inc | 2.5B | -4.3x | --- |
P3 Health Partners Inc | 191.1M | -1.0x | --- |
Novavax Inc | 1.8B | -4.1x | --- |
Halozyme Therapeutics Inc | 5.7B | 18.5x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.